Down arrow

Events

  • 23 October 2026
    ERA Chair Sessions

    Fleming's External Seminar on Friday 23/10/26 at 13:00 - Lecture theatre, "Beyond Good and Bad Gut Bacteria: Decoding Microbial Behavior", by Professor Gianni Panagiotou, PhD, Head of the Department of Microbiome Dynamics, Leibniz-HKI, Germany; Faculty of Biological Sciences, Friedrich Schiller University, Germany; Jena University Hospital, Friedrich Schiller University, Germany; Faculty of Medicine, The University of Hong Kong, China.

  • 5 October 2026
    Seminar

    Fleming's External Seminar on Monday 5/10/26 at 13:00 - Lecture theatre, "Engineering nanostructured materials for biomedicine", by Georgios A. Sotiriou, Professor, SciLifeLab and Department of Chemistry, Stockholm University, Solna, Sweden.

  • 1 September 2026
    ERA Chair Sessions

    Fleming's Seminar Series “BSRC Fleming ERA Chair Sessions” on Tuesday 01/09/26 at 13:00 - Lecture theatre, "Next Generation Therapeutic Strategies for RAS-Mutant Cancers", by Professor Poulikos Poulikakos, Cancer Mechanisms Program, Mount Sinai Tisch Cancer Center, Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, USA.

  • 1 July 2026
    Leader Seminar Series

    Fleming's Leader Seminar Series on Wednesday 01/07/26 at 13:00 - Lecture theatre, "Engineering bacterial motility: prediction, evolution and rebuilding of the flagellar motor", by A/Prof Matthew A. Baker, Scientia Associate Professor, School of Biotechnology and Biomolecular Sciences (BABS), UNSW Sydney, Australia, Associate Dean International Partnerships, Faculty of Science.

  • 25 June 2026
    Seminar

    Fleming's External Seminar on Thursday 25/6/26 at 13:00 - Lecture theatre, "Beyond Morphology: Unbiased Spatial Omics For Next Generation Histopathology", by Javier Batista Perez, PhD, DNA, Cell, and Spatial Omics (DCS) Specialist, MGI Group, Italy.

  • 12 June 2026
    Seminar

    Fleming's External Seminar on Friday 12/6/26 at 13:00 - Lecture theatre, "CCR7+ activated dendritic cells are crucial for spontaneous and therapy-induced anti-tumour immunity", by Maria Koufaki, PhD, Postdoctoral Scientist, Cancer Research UK Manchester Institute, The University of Manchester.